Oxehealth Listed in CB Insights’ Top Digital Health Companies of 2021

CB Insights have just unveiled their third annual Digital Health 150 — a ranking of the 150 most promising digital health start-ups in the world, all using digital technology to transform healthcare – and we are very proud to say that Oxehealth made it on the list in the Screening, Monitoring and Diagnostics category!

According to a recent article from CB Insights, this year’s group were selected from a pool of over 11,000 companies, including applicants and nominees. “They were chosen based on several factors, including data submitted by the companies, company business models and momentum in the market, and Mosaic scores, CB Insights’ proprietary algorithm that measures the overall health and growth potential of private companies.”

This year’s Digital Health 150 cohort has raised a combined figure of approximately $14.9 billion in aggregate funding since 2016. The group includes start-ups at varying investment stages of development, from very early-stage companies to well-funded scale-ups.

To learn more about CB Insights, or to access the full Digital Health 150 list, click here.

‍